Among many things, in this episode we discuss: - Obsidian's lead program, OBX-115, a modified TIL cell therapy - The critical role of TCR sequencing in profiling infusion products, tracking clonotypes, and identifying biomarkers for therapy response. Listen/View here: youtu.be/J41q0fUqeVo?...
The Repertoire Room: Episode 3 - Arman Aksoy (Obsidian Therapeutics)
YouTube video by ImmuneWatch
youtu.be